five
monoclon
antibodi
mab
recombin
nucleocapsid
protein
np
sever
acut
respiratori
syndrom
sar
caus
coronaviru
cov
develop
hybridoma
technolog
epitop
map
western
blot
show
antisarscov
np
mab
bind
distinct
domain
np
antisarscov
np
mab
high
specif
potenti
ideal
candid
develop
earli
sensit
diagnost
assay
sarscov
sever
acut
respiratori
syndrom
sar
sever
form
pneumonia
due
infect
coronaviru
cov
adapt
humantohuman
transmiss
sever
cell
type
human
bodi
suscept
sarscov
infect
replic
turn
trigger
seri
patholog
chang
develop
specif
diagnost
test
sarscov
paramount
import
effect
treatment
infect
patient
prevent
futur
sar
outbreak
nucleocapsid
protein
np
predomin
virusderiv
structur
protein
shed
larg
amount
serum
nasopharyng
aspir
npa
throat
wash
sampl
fecal
matter
urin
earli
day
infect
earlier
studi
shown
detect
np
variou
bodi
fluid
use
specif
monoclon
antibodi
mab
rais
np
immunodomin
epitop
use
enzymelink
immunosorb
assay
elisa
indirect
fluoresc
assay
enhanc
chemiluminesc
immunoassay
western
blot
lack
effect
sensit
easytous
assay
consid
one
major
drawback
prevent
sar
outbreak
henc
develop
easytous
sensit
specif
assay
np
could
way
forward
prevent
futur
sar
pandem
studi
shown
sarscov
np
detect
acut
phase
sar
infect
specif
mab
compar
structur
protein
sarscov
detect
np
variou
sampl
patient
suspect
sar
includ
serum
urin
fecal
matter
npa
throat
wash
sampl
saliva
earli
day
infect
also
carri
indic
np
rapidli
shed
larg
amount
describ
develop
sarscov
mab
character
analyz
bind
site
epitop
map
crossreact
relat
np
anim
human
cov
five
balbc
mice
immun
escherichia
coli
express
sarscov
np
follow
set
immun
protocol
base
high
antibodi
titer
splenocyt
isol
immun
mice
fuse
freshli
grown
myeloma
cell
use
polyethylen
glycol
third
reclon
step
five
stabl
antisarscov
np
clone
gener
sarscov
np
design
antisarscov
np
hybridoma
clone
cultur
supernat
purifi
protein
g
agaros
chromatographi
rang
immunoglobulin
g
igg
yield
mgliter
cell
cultur
supernat
isotyp
five
mab
done
use
commerci
avail
isotyp
kit
sigmaaldrich
result
demonstr
heavi
chain
three
antisarscov
np
mab
class
class
light
chain
found
kappa
mab
western
blot
puriti
antisarscov
np
mab
evalu
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
analysi
show
specif
purifi
mab
sarscov
np
antigen
epitop
map
studi
done
np
subfrag
determin
antisarscov
np
mab
bind
specif
region
np
separ
overlap
epitop
determin
bind
region
mab
np
three
differ
truncat
fragment
clone
express
e
coli
codonoptim
recombin
np
amino
acid
aa
gene
fragment
aa
aa
aa
use
determin
specif
mab
western
blot
fig
protein
gpurifi
antibodi
use
three
mab
found
react
specif
fulllength
sarscov
np
well
specif
subfrag
sarscov
np
antigen
bound
fulllength
np
bound
fulllength
np
respect
differ
sensit
suggest
partial
overlap
epitop
complet
nonoverlap
epitop
remain
antibodi
show
signal
fragment
exhibit
bind
fulllength
np
mab
clearli
show
specif
bind
mab
bound
use
develop
sensit
heterosandwich
elisa
detect
sarscov
np
antigen
mab
show
specif
reactiv
np
subfrag
weakli
bound
whole
np
antigen
indic
low
specif
reactiv
np
antigen
though
epitop
map
analysi
may
determin
specif
amino
acid
mab
bind
indic
specif
region
antigen
protein
help
develop
pair
mab
util
develop
heterosandwich
immunoassay
sandwich
elisa
optim
concentr
gml
use
captur
antibodi
gml
use
detector
antibodi
fig
concentr
determin
initi
experi
use
checkerboard
titrat
sandwich
elisa
use
checkerboard
titrat
show
captur
antibodi
c
highest
optic
densiti
od
valu
biotinyl
use
detect
antibodi
detect
biotinyl
detect
antibodi
captur
antibodi
yield
compar
lower
od
valu
partial
competit
sandwich
elisa
could
due
differ
affin
mab
np
antigen
steric
hindranc
antibodyinduc
conform
chang
antigen
upon
antibodi
bind
base
data
develop
monospecif
bispecif
antibodybas
immunoswab
assay
pointofcar
applic
sarscov
np
sequenc
show
amino
acid
homolog
np
sequenc
cov
crossreact
sarscov
human
cov
report
previous
np
sarscov
clone
express
e
coli
studi
bovin
cov
human
cov
clone
express
e
coli
clone
express
high
level
np
desir
size
fig
express
confirm
western
blot
probe
antihi
mab
fig
specif
newli
develop
mab
differ
np
evalu
western
blot
fig
g
five
mab
exhibit
strong
bind
sarscov
np
crossreact
np
bovin
cov
observ
anoth
studi
use
antibodi
develop
bispecif
mab
establish
novel
bispecificantibodi
purif
method
use
differ
combin
mab
bispecif
mab
igi
develop
pointofcar
immunoswab
assay
high
sensit
thu
new
mab
could
use
reagent
diagnost
well
function
analysi
np
infect
work
support
research
grant
nation
institut
allergi
infecti
diseas
part
nation
institut
health
plasmid
contain
bovin
cov
pgembcn
human
cov
np
gene
receiv
gift
alexand
n
zakhartchouk
vaccin
infecti
diseas
organ
vido
univers
saskatchewan
saskatoon
saskatchewan
canada
lia
van
der
hoek
laboratori
experiment
virolog
depart
medic
microbiolog
center
infect
immun
amsterdam
cinima
academ
medic
center
univers
amsterdam
amsterdam
netherland
respect
